Health utility values of breast cancer treatments and the impact of varying quality of life assumptions on cost‐effectiveness
LM Kregting, NJMC Vrancken Peeters… - … Journal of Cancer, 2024 - Wiley Online Library
In breast cancer research, utility assumptions are outdated and inconsistent which may
affect the results of quality adjusted life year (QALY) calculations and thereby cost …
affect the results of quality adjusted life year (QALY) calculations and thereby cost …
Cost‐effectiveness of polatuzumab vedotin in combination with chemoimmunotherapy (pola‐R‐CHP) in previously untreated diffuse large B‐cell lymphoma in …
S Kambhampati, E Shumilov, M Saumoy… - British Journal of …, 2023 - Wiley Online Library
We evaluated the cost‐effectiveness of frontline polatuzumab vedotin‐R‐CHP (pola‐R‐
CHP) treatment for patients with diffuse large B‐cell lymphoma (DLBCL) in Germany by …
CHP) treatment for patients with diffuse large B‐cell lymphoma (DLBCL) in Germany by …
Health-related Quality of Life using the EQ-5D-5L: normative utility scores in a Dutch female population
ME Clarijs, LM Kregting, NT van Ravesteyn… - Quality of Life …, 2023 - Springer
Purpose Normative utility scores represent the health related quality of life of the general
population, are of utmost importance in cost-effectiveness studies and should reflect relevant …
population, are of utmost importance in cost-effectiveness studies and should reflect relevant …
[PDF][PDF] Economic Evaluations of Cancer Screening Tests in the US: A Systematic Literature Review (SLR)
Z Cong, GG Goldsmith-Martin, A Phalguni, AE Brown - Age - grail.com
■ Anal: anal cytology, digital ano‑rectal examination■ Bladder: urinalysis, urine cytology,
urine tests for tumor markers (UroVysion, bladder tumor‑associated antigen [BTA] …
urine tests for tumor markers (UroVysion, bladder tumor‑associated antigen [BTA] …